TAP Biosystems (formerly The Automation Partnership) provides advanced automation systems and services to improve productivity in life science research, development and production.
For over 20 years, TAP has been the leader in the design and development of automated cell culture systems with applications in bioprocessing, drug discovery and regenerative medicine.
TAP also provides custom automation solutions for biobanking, biological sample management, compound management and advanced high throughput screening applications.
TAP's systems are installed in the world's top pharmaceutical and biotechnology companies; key service providers and leading research institutions including: Amgen, AstraZeneca, ATCC, Bristol-Myers Squibb, Cambridge Antibody Technology, Exelixis, Laboratoires Fournier, Loughborough University, GlaxoSmithKline, Max Planck Institute, Merck, Novartis, Oxford University, Pfizer, Roche, Sanofi Aventis, Stem Cell Sciences, UK Biobank and Wyeth.
TAP is a private company with headquarters in Royston near Cambridge, UK and a US sales and support office in Wilmington, Delaware.